Dimensional Changes: Randomized Clinical Trial
Dimensional Changes of Autogenous Free Epithelialized Gingival Grafts on Different Bed Preparations Among Dental Patients With Thin Tissue Phenotypes: A Randomized Clinical Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the dimensional changes in the short and long-term in patients with thin gum tissues who have gum grafts placed on either denuded bone or gum grafts placed on a bone with some tissues remaining. The main question this study aims to answer is: \- Does the placement of free-epithelized gingival grafts (gum grafts) on full thickness bed preparation (having all of the tissue removed from the bone) lead to similar clinical, digital, and patient-related outcomes and measurements over a period of 12 months versus split thickness bed preparation (where a small layer of tissue is left over the bone) in patients with thin gum tissue phenotypes (gum tissue is generally less than 1.5 millimeters) who are in need of soft tissue augmentation procedures? Participants will be asked to attend 8 visits, which include: (i) screening visit, (ii) prophylaxis visit, (iii) random assignment to Group A or Group B along with surgery and digital data collection, (iv) 2-week post-operative visit, (v) 6-week post-operative visit, (vi) 3-month follow-up visit, (vii) 6-month follow-up visit, (viii) 12-month follow-up visit. Also, Group A will have a free epithelialized gingival/mucosal graft (gum graft) placed on full thickness periosteal bed preparation where all of the tissue was removed (test group). Group B will have a free epithelialized gingival/mucosal graft (gum graft) on split thickness periosteal bed preparation where only a portion of the tissue was removed (control group). Researchers will compare Group A and Group B to see if there is a difference in clinical, digital, and patient-related outcomes and measurements over a period of 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2028
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2023
CompletedFirst Posted
Study publicly available on registry
January 13, 2023
CompletedStudy Start
First participant enrolled
August 1, 2028
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2030
Study Completion
Last participant's last visit for all outcomes
March 1, 2031
August 19, 2025
August 1, 2025
1.9 years
January 4, 2023
August 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Gingival Thickness as assessed by measurement.
Tissue changes will be assessed in millimeters and percentage.
Multiple time points (i.e., Baseline, 3 months, 6 months, 12 months)
Study Arms (2)
Gum Graft Placed on Denuded Bone
EXPERIMENTALSubjects in this arm will have a free epithelialized gingival/mucosal graft (gum graft) placed on full thickness periosteal bed preparation where all of the tissue was removed (test group).
Gum Graft Placed on Split Thickness Periosteal Bed Preparation
ACTIVE COMPARATORGroup B will have a free epithelialized gingival/mucosal graft (gum graft) on split thickness periosteal bed preparation where only a portion of the tissue was removed (control group).
Interventions
The provider will administer local anesthesia into the subject's gum in order to numb both the subject's donor and recipient areas for gum grafts. Next, the provider will use a surgical blade to dissect the gum graft from the subject's donor site. At the subject's recipient gum recession defect site, the provider will remove all of the subject's tissue, so that the bone is fully exposed before placing a gum graft from the donor site. Afterward, the provider will place sutures in the subject's recipient site in order to promote healing/re-growth.
The provider will administer local anesthesia into the subject's gum in order to numb both the subject's donor and recipient areas for gum grafts. Next, the provider will use a surgical blade to dissect the gum graft from the subject's donor site. At the subject's recipient gum recession defect site, the provider will dissect some of the tissue at the subject's recipient site but still keep a small layer of tissue at the subject's recipient site before placing a gum graft from the donor site. Afterward, the provider will place sutures in the subject's recipient site in order to promote healing/re-growth.
Eligibility Criteria
You may qualify if:
- Patients 18-95 years of age
- Inactive periodontal disease
- Lack of, or an insufficient (less than 2 millimeters) band of keratinized tissue width on the buccal site (closest to the cheek)
- Shallow vestibule depth (the space between the soft tissue (lips and cheeks), and the teeth and gums)
- Thin gingival phenotype (less than 1.5mm of gum tissue depth).
- Aberrant frenum attachment in need of free-epithelized gingival grafts.
- At least one RT1, 2, or 3 (Cairo's classification) gingival recession defect on the mandibular anterior sextant (Teeth #22-27).
- Non-smokers or past smokers (those who have stopped at minimum 6 months ago).
- Patient willing and able to follow instruction related to the study procedures.
You may not qualify if:
- Previous soft tissue augmentation procedures at the area of interest.
- Current smokers (Light smokers meaning less than 10 cigarettes/day, heavy smokers meaning more than 10 cigarettes/day, or social smokers)
- Uncontrolled systemic disease (uncontrolled diabetes defined by blood sugar HbA1c greater than 7%)
- Any active local or systemic infections
- Any diseases or medications that may compromise normal wound healing
- Currently receiving chemotherapy or radiotherapy or a history of radiotherapy in head and neck area.
- Severe hematologic (blood) disorders
- Pregnancy or nursing mother
- Patients undergoing orthodontic therapy
- Patients taking antibiotics in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa College of Dentistry and Dental Clinics
Iowa City, Iowa, 52242, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos Garaicoa, DDS, MS
University of Iowa College of Dentistry
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
January 4, 2023
First Posted
January 13, 2023
Study Start (Estimated)
August 1, 2028
Primary Completion (Estimated)
July 1, 2030
Study Completion (Estimated)
March 1, 2031
Last Updated
August 19, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share